Mission
WE IMPROVE ACCESS TO ESSENTIAL HEALTHCARE FOR PATIENTS BY MOTIVATING PROVIDERS TO DELIVER AFFORDABLE AND QUALITY CARE, ENABLED BY TECHNOLOGY.
Public Charity
MAISHA MEDS INC
MAISHA MEDS INC, of SAN FRANCISCO, CA, is a Public Charity tracked in Imperigo's IRS 990 database. The 2024 filing shows $6.0M in revenue, $6.0M in expenses, $1.2M in total assets. 9 publicly reported grants to this organization, totaling roughly $1.9M, appear in IRS filings.
EIN: 814618222
SAN FRANCISCO, CA
International Development
NTEE: Q30
Latest filing: 2024
Total Revenue$6.0M
Total Expenses$6.0M
Total Assets$1.2M
Grant Records9
Funding Total$1.9M
Filing Years2019–2024
Where $100 goes at Maisha Meds Inc
How Maisha Meds Inc divides every $100 it spends, from its own Form 990 filings, averaged across 6 years.
$91
Programs
the work itself
$7
Management
running the organization
$2
Fundraising
raising the next dollar
Inside the $91 for programs
$72
Malaria treatment
$15
Vision
$4
Hiv prep
Source: Form 990 filings with the IRS, latest fiscal year 2024. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
For grant recipient's exempt purposes
$1,350,000
General Support
$300,000
RESEARCH AND TECHNICAL ASSISTANCE GRANTS
$50,000
For grant recipient's exempt purposes
$7,500
For grant recipient's exempt purposes
$7,500
Showing up to 5 of 9 total records — full history available with membership.
Officers & Directors
CHAIR
Amrita Ahuja
DIRECTOR
Ayanda Mngadi
DIRECTOR
Grant Ingersoll
CFO
Jeff Francis
CTO
Jenny Cheng
CEO
Jessica Vernon
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $6.0M | $6.0M | $1.2M |
| 2023 | $659K | $5.2M | $1.3M |
| 2022 | $6.9M | $3.8M | $5.8M |
| 2020 | $1.9M | $1.3M | $2.0M |
| 2019 | $1.9M | $731K | $1.3M |
Between 2019 and 2024, reported annual revenue grew from $1.9M to $6.0M (+221%), with total assets most recently reported at $1.2M.
Interactive year-over-year charts and full filing details available with membership.